| 1 |
33508166 | Investigating differences between tamoxifen resistant and sensitive breast cancer cells with flow cytometry. | 2021 Feb |
2 |
| 2 |
31490549 | IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer. | 2020 Apr 15 |
8 |
| 3 |
32435229 | IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation. | 2020 |
2 |
| 4 |
29028222 | Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer. | 2018 Apr 1 |
2 |
| 5 |
29353882 | IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer. | 2018 Apr |
2 |
| 6 |
28096479 | IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells. | 2017 Apr |
10 |
| 7 |
28468775 | Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds. | 2017 Jul |
1 |
| 8 |
26706833 | The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis. | 2016 Apr |
1 |
| 9 |
26803986 | HOX genes: Major actors in resistance to selective endocrine response modifiers. | 2016 Apr |
1 |
| 10 |
27178332 | ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling. | 2016 Jun |
2 |
| 11 |
25882671 | Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion. | 2015 |
1 |
| 12 |
23459444 | Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen. | 2014 Feb |
2 |
| 13 |
24532107 | Dynamics of IGF-1R expression during endocrine breast cancer treatment. | 2014 Aug |
1 |
| 14 |
25362932 | Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer. | 2014 Nov 3 |
1 |
| 15 |
22573715 | Acquired resistance to tamoxifen is associated with loss of the type I insulin-like growth factor receptor: implications for breast cancer treatment. | 2012 Jul 1 |
3 |
| 16 |
22835717 | Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure. | 2012 Nov |
2 |
| 17 |
23074235 | Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment. | 2012 Dec |
1 |
| 18 |
20890664 | Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia. | 2011 Mar |
1 |
| 19 |
21057462 | Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma. | 2011 Feb |
1 |
| 20 |
21273576 | Measuring IGF-1, ER-α and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer. | 2011 Jan |
1 |
| 21 |
21595894 | Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. | 2011 May 19 |
2 |
| 22 |
21734071 | Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment. | 2011 Oct |
1 |
| 23 |
21939528 | erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines. | 2011 Sep 22 |
2 |
| 24 |
19002577 | Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha. | 2009 Dec |
1 |
| 25 |
19138696 | Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells. | 2009 Jul |
1 |
| 26 |
19173092 | An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer. | 2009 |
1 |
| 27 |
19435893 | Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer. | 2009 May 15 |
1 |
| 28 |
18245484 | Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. | 2008 Feb 1 |
3 |
| 29 |
18508432 | The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance. | 2008 May 1 |
1 |
| 30 |
18583420 | ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells. | 2008 Oct |
1 |
| 31 |
18769129 | Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells. | 2008 Sep |
1 |
| 32 |
19074892 | Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. | 2008 Dec 15 |
1 |
| 33 |
16037379 | Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor. | 2005 Nov |
2 |
| 34 |
16113104 | Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. | 2005 Jul |
4 |
| 35 |
15072444 | Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells. | 2004 Mar-Apr |
1 |
| 36 |
10940491 | Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. | 2000 Jul 25 |
6 |
| 37 |
10940495 | Effect of tamoxifen treatment on the endometrial expression of human insulin-like growth factors and their receptor mRNAs. | 2000 Jul 25 |
3 |
| 38 |
10070856 | Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line. | 1999 Feb |
3 |
| 39 |
9205064 | Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. | 1997 Jul 1 |
8 |
| 40 |
9142960 | Insulin-like growth factors in breast cancer. | 1996 |
1 |
| 41 |
8746077 | Insulin-like growth factors and breast cancer. | 1995 |
1 |